Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin A in the Treatment of Frostbite Sequelae - a Randomized, Double Blind, Placebo-controlled Study

NCT06460194 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT06460194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06460194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin A in the Treatment of Frostbite Sequelae - a Randomized, Double Blind, Placebo-controlled Study
Lead sponsor
University Hospital of North Norway
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2022
Completion date
June 10, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cold hypersensitivity, pain, nerve, sensory disorders, vascular system injuries, vibration; disorder